Non-invasive vagus nerve stimulation for treating atrioventricular reentrant tachycardia
Non-invasive Left-sided Cervical Vagus Nerve Stimulation for Atrioventricular Reentrant Tachycardia
This study is testing if a new, non-invasive treatment using electrical stimulation on the vagus nerve can help people with atrioventricular reentrant tachycardia get their heart rhythm back to normal before they need a more invasive procedure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Guangzhou Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06219343 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of non-invasive vagus nerve stimulation in patients with atrioventricular reentrant tachycardia. Participants will receive electrical stimulation on the left vagus nerve while their heart rhythms are monitored. The goal is to determine if this method can effectively restore normal heart rhythm prior to radiofrequency ablation. The study aims to provide a safer and less invasive treatment option for patients experiencing this condition.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with atrioventricular reentrant tachycardia who meet specific diagnostic criteria and have no psychiatric or communication disorders.
Not a fit: Patients who do not meet the diagnostic criteria for supraventricular tachycardia or have mental anomalies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could offer a non-invasive alternative for managing atrioventricular reentrant tachycardia, potentially reducing the need for more invasive procedures.
How similar studies have performed: While the approach of non-invasive vagus nerve stimulation is relatively novel, similar studies have shown promise in other conditions, suggesting potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt) need to be met. 2. All need to be free of psychiatric abnormalities, verbal communication disorders, and have good compliance. 3. The patients and their families gave informed consent and signed the informed consent form. Exclusion Criteria: 1. Does not meet the relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt). 2. Mental anomalies, verbal communication disorders, poor adherence 3. Those who do not consent to participate in this clinical trial
Where this trial is running
Guangzhou, Guangdong
- Ai-lan Chen — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Ai-lan Chen
- Email: 1228327958@qq.com
- Phone: 13719198832
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.